Closed hospital In New Mexico retrofitted to treat COVID-19 patients

The building could be used to handle general overflow patients as well


The former Lovelace hospital at Gibson Medical Center in Albuquerque was retrofitted to treat COVID-19 patients, according to an article on the Albuquerque Journal website.

The building could be used to handle general overflow patients as well.

The operation will be staffed in large part by members of New Mexico’s Medical Reserve Corps. The hospital could have as many as 200 beds.

The renovation cost $3.6 million. Meanwhile, another $2.5 million was spent getting the gym at Miyamura High School in Gallup set up to house 60 patients

Read the article.

 

 



May 5, 2020


Topic Area: Industry News


Recent Posts

The Future of the Global Hospital Hygiene Market

A market study details the current state of the global hygiene market and the factors that are expected to make a big difference in the next decade.


Rethinking Fire Safety Inspections

Digital tools bridge the gap between growing facility complexity and workforce limitations, allowing teams to maintain the highest safety standards.


The Ohio State University Wexner Medical Center Officially Opens

With the new hospital comes other changes, including new street and building names on the medical campus.


Healthcare and Resilience: A Pledge for Change

Climate resilience and reducing environmental impact drive voluntary program targeting hospitals.


Texas Health Resources Announces New Hospital for North McKinney

Expected to open in 2028, the hospital will feature 60 beds initially with plans to double in capacity to accommodate for future community growth.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.